CTI BIOPHARMA CORP·4

May 2, 5:48 PM ET

CTI BIOPHARMA CORP 4

4 · CTI BIOPHARMA CORP · Filed May 2, 2017

Insider Transaction Report

Form 4
Period: 2017-04-29
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2017-04-2934,7360 total
    Common Stock (34,736 underlying)
  • Exercise/Conversion

    Common Stock

    2017-04-29+34,73688,318 total
Footnotes (3)
  • [F1]CTIC completed a 1-for-10 reverse stock split in January 2017. All share amounts reported in this Form 4 have been retroactively adjusted to reflect this stock split.
  • [F2]Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
  • [F3]This restricted stock unit was granted on April 29, 2016 and vested on April 29, 2017.

Documents

2 files